SA
CLBT icon

Strategic Advisors’s Cellebrite CLBT Stock Holding History

Strategic Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-136,860
Closed -$1.89M – 169
2026
Q1 		$1.89M Sell
136,860
-7,180
-5% -$108K 0.31% 74
2025
Q4 		$2.6M Buy
144,040
+110
+0.1% +$1.98K 0.41% 59
2025
Q3 		$2.67M Buy
143,930
+42,903
+42% +$674K 0.43% 56
2025
Q2 		$1.62M Buy
101,027
+31,829
+46% +$567K 0.32% 68
2025
Q1 		$1.34M Buy
69,198
+40,116
+138% +$844K 0.26% 81
2024
Q4 		$641K Buy
29,082
+950
+3% +$18.3K 0.12% 124
2024
Q3 		$474K Buy
+28,132
New +$417K 0.09% 145

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Strategic Advisors's CLBT Position: Q2 2026 in Review

Strategic Advisors sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 136,860 shares — an estimated $1.89M sold.

Strategic Advisors first reported a position in CLBT in Q3 2024 and held it in 7 quarters. The position peaked at $2.67M in Q3 2025. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Strategic Advisors reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Strategic Advisors sold 136,860 Cellebrite shares in Q2 2026, an estimated $1.89M.
  • Strategic Advisors first reported a position in Cellebrite in Q3 2024 and held it in 7 quarters.
  • Strategic Advisors's Cellebrite position peaked at $2.67M in Q3 2025.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Strategic Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.